01.23.26 -- How Outsourcing Meets Precision: A Formula For CDMO Interactions

Join Outsourced Pharma Chief Editor Jeff Buguliskis and our panel of industry experts as they share practical advice, reveal what to look for beyond the surface, and answer your toughest questions about selecting a CDMO partner that can truly deliver. Register for free today!

Convert uncertainty into opportunity by mastering scientific rigor, operational agility, and strategic foresight. Partnerships and proactive regulatory planning are essential for minimizing risk.

Learn more about an ex vivo cultured human skin explant model in which pathological tissue integrity, barrier function, and metabolic stability have been characterized over time.

Explore the key advantages of stick-pack formats for pharmaceuticals and nutraceuticals, from enhanced product safety and cost-efficiency to improved compliance and marketability.

Decentralized trials and biotech product needs are changing how investigational products reach patients. New market research reveals trends.

Assimilate how AI can be safely and effectively deployed in regulated pharma environments, with practical guidance on risk, governance, and lifecycle management rooted in GAMP 5 principles.

Selecting the right GLP-1 peptide manufacturing route determines the specific impurity profile and regulatory strategy. Robust analytical methods are essential for ensuring efficacy and patient safety.

Enteric polymer coatings play a crucial role in oral drug formulations, protecting the API from harsh gastric conditions and enabling targeted drug delivery with optimized release based on location.

See the formulation and manufacturing considerations for amorphous solid dispersions (ASDs), with a focus on hot melt extrusion (HME) as a scalable and cost-effective technology option.

Technological developments have led to growth of fermentation for a myriad of applications. Uncover the impact of the evolution of synthetic biology on modern fermentation practice.

Discover why this highly complex process requires a unique level of CDMO expertise that can only be gained through extensive experience with developing a broad range of APIs.

Read how using mesoporous silica as a means to enhance the micronization process is redefining the path to more efficient and reliable API formulation.

This event offers short, interactive digital presentations from leading CDMOs showcasing their capabilities, facilities, and available capacity for biopharma development and fill-finish manufacturing. Attendees can explore sterile filling, lyophilization, and packaging technologies, and ask questions live. Open to pharma and biotech professionals, industry consultants, investment firms, and CDMO sponsors seeking manufacturing solutions. Click here to learn more.

Route scouting service helps biotech partners navigate the complexities of API development and accelerate the delivery of life-changing medicines to market.

Browse our comprehensive catalog of Active Pharmaceutical Ingredients and Intermediates by scrolling through the complete list below for detailed product information.